cerrar
Tagged with clinical trials

Habib Bennaceur – Country Manager, AstraZeneca, Algeria
The country manager of a British biopharmaceutical company sheds light on Algeria's potential for conducting clinical trials and offers his views on…

Mohamed Benali Khoudja – Head strategy Development North…
The general manager of a leading British research-based pharmaceutical company discusses Algeria's suitability as a destination for pre-clinical and…

Arianne Clinical Research Algeria – Cellia Habita, President…
The global CEO of Arianne, who herself happens to be American-Algerian, outlines why, in an era of clinical research globalisation, the country has…

LSK Global PS – Young-Jack Lee, CEO – South Korea
LSK Global PS CEO Young-Jack Lee discusses the influence of global CROs on the quality of Korean research, and outlines his own strategy for competing…

Sanofi Korea – Kay Bae, General Manager
Sanofi’s Korean affiliate is the fifth largest recipient of clinical trial investments after the United States, France, Germany and the United…

Astellas Korea – Jeong Hai-Do, President
The president of Astellas Korea offers his perspectives on Korea as a base for primary and clinical research, and the company's recent partnerships in…

P&K Skin Research Center – Kim Beom-Joon, Head Researcher…
The head researcher at P&K Skin Research Center discusses the potential of South Korea as a clinical trial hub, and the company's current…

Hanyang University Hospital for Rheumatic Diseases – Bae…
The director of the Hanyang University Hospital for Rheumatic Diseases (HUHRD), discusses Korea’s leading role in developing biosimilars as well as…

KoNECT – Deborah Chee, President – South Korea
The Korea National Enterprise for Clinical Trials (KoNECT) was established in 2007 by the Korean government to meet the increasing demand for local…

Parexel Spain – Pilar Rivas, Associate Director
Pilar Rivas, associate director of global contract research organization Parexel's Spanish affiliate, discusses cultural differences across Spain and…

Venter Pharma – Jose Luis Martin, CEO – Spain
The CEO of Venter Pharma explains the challenges of bringing a diagnostic drug to the market, and how they hope to leverage the science behind their…

UNC Hemoderivados – Catalina Massa, Executive Director…
The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here